Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety study of KRP-AB1102 in Japanese patients with COPD
jRCT2080221930Phase 3
- Sponsor
- Kyorin Pharmaceutical
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of aclidinium in chronic obstructive pulmonary disease (COPD), sponsored by Kyorin Pharmaceutical.
02
Drugs
aclidinium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCT2080221930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221930.